ADELAIDE, Australia--(BUSINESS WIRE)--Medical device company, Signostics, announced today it has clearance from the U.S. Food and Drug Administration to launch the SignosRT Bladder, the company’s new ...

Patients with an aggressive form of bladder cancer could receive treatment in nearly half the time if a cheaper, less-invasive test is used, research has found. Researchers from the University of ...

With iQ+ Bladder, Butterfly expands outside its core point-of-care ultrasound market to better serve the bladder scanning market with its proprietary Ultrasound-on-Chip™ technology. The bundled ...

An estimated 33 million people in the United States experience overactive bladder (OAB). Though OAB is common, it is not a normal part of aging. OAB occurs when the bladder muscles are unable to relax ...

The main cause of bladder cancer is smoking. Some other risk factors for developing the disease include a person’s age and exposure to certain chemicals. In 2019, an estimated 712,644 people were ...

Butterfly Network BFLY recently announced the availability of its first specialty product, the iQ+ Bladder, in the United States. This launch marks a significant expansion for Butterfly, as it moves ...